Atossa Genetics Regains Compliance With NASDAQ Listing Requirement

Life Science Investing News

NASDAQ today notified Atossa Genetics that the company was once more compliant with NASDAQ’s minimum closing bid price listing rule 5550(a)(2). According to the press release, “Staff has determined that for the last 10 consecutive business days, from August 26 to September 9, 2016, the closing bid price of the Company’s common stock has been at $1.00 per share or greater.”

NASDAQ today notified Atossa Genetics (NASDAQ: ATOS) that the company was once more compliant with NASDAQ’s minimum closing bid price listing rule 5550(a)(2).
As quoted in the press release:

Atossa received notice from NASDAQ stating, in part, that the “Staff has determined that for the last 10 consecutive business days, from August 26 to September 9, 2016, the closing bid price of the Company’s common stock has been at $1.00 per share or greater. Accordingly, the Company has regained compliance with Listing Rule 5550(a)(2) and this matter is now closed.”

Read the full press release here.

atossa genetics genetics nasdaq compliance regulatory news Company News